Promising company that's not short of shortcomings - Recensione dipendente - Manager presso Tempus AI

2,0
29 ott 2017
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

+ The mission of our work and the numerous smart people driving what we did at Tempus was very inspiring + Nimble company that quickly responded to changing focus, needs

Svantaggi

- Pervasive feeling of ingroup and outgroup with most of the company (and particularly leaders) being ex-Grouponers - External barriers in the healthcare industry posed a challenge for the core of Tempus' work - Felt like my function was under a great degree of undue scrutiny, almost dismissal - Pay is far below benchmark - For a startup, collaboration was lacking - Top leadership didn't seem open to having a dialogue with employees

Esplora altre recensioni su Tempus AI

5,0
4 lug 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Good place to work at, very impactful work.

Svantaggi

No cons i can think of tbh.

2,0
12 mar 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

As mentioned work is great since it is cancer research and my coworkers are amazing. Immediate leadership managers and Sr. managers are good as well but somewhat unorganised. Work life balance is good also and health insurance as long as you get BCBS PPO with copay otherwise you're screwed paying off deductible.

Svantaggi

Pay is below industry average, and there is essentially no room to negotiate a better raise. Employees are actively discouraged from discussing compensation, and whatever leadership decides is final, there are no exceptions. If you try to escalate concerns or request a conversation with senior leadership, such as a senior director or VP, you’ll quickly find yourself getting the runaround. Leadership prefers to hide behind layers of management rather than engage directly. There is also no clear or transparent path for career advancement. Opportunities technically exist, but they are extremely limited. You can do everything right, receive a top rating of 5 on your annual performance review, and still not be promoted to manager or see any meaningful improvement in compensation. To make matters worse, the billionaire CEO and founder has said things like, “Don’t worry about pay because we’re curing cancer.” Statements like that feel incredibly out of touch when employees are earning $50k–$60k a year and receiving annual raises of only about $2,000. On top of that, equity is almost impossible to obtain. You have to fight for even the possibility of it, because stock or equity compensation is reserved almost exclusively for the C-suite and directors, with virtually nothing available for employees below that level.

2
Vedi recensioni per: Utile|Valutazione|Data|Tutto